Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 1, 2017
Outcome of patients with chronic obstructive pulmonary disease and severe coronary artery disease who had a coronary artery bypass graft or a percutaneous coronary interventionPontus Andell, Johan Sjögren, Gorav Batra, et al.
Plos One|January 13, 2022
Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation-A SWEDEHEART studyChristina Christersson, Claes Held, Angelo Modica, et al.
Open Heart|January 30, 2024
Thromboembolic and bleeding events after valvular intervention in patients with atrial fibrillationEbba-Louise Skogseid, Gorav Batra, Johan Westerbergh, et al.
Scandinavian Cardiovascular Journal : SCJ|July 12, 2019
Diagnosing type 2 myocardial infarction in clinical routine. A validation studyAnton Gard, Bertil Lindahl, Gorav Batra, et al.
Upsala Journal of Medical Sciences|September 29, 2018
Atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcomeGorav Batra, Anders Ahlsson, Bertil Lindahl, et al.
Open Heart|September 14, 2022
Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney diseaseGorav Batra, Angelo Modica, Henrik Renlund, et al.
Journal of the American Heart Association|November 10, 2023
Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non-Vitamin K Oral Anticoagulants Across Varying Body Mass IndexAstrid Fritz Hansson, Karin Jensevik Eriksson, Christina Christersson, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|December 2, 2025
Association between quality of care indicators and clinical outcomes in patients undergoing transcatheter aortic valve implantation: insights from SWEDEHEARTKonrad Nilsson, Stefan James, Jenny Backes, et al.
Open Heart|March 1, 2024
Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort studyAstrid Fritz Hansson, Angelo Modica, Henrik Renlund, et al.
Journal of the American Heart Association|March 22, 2017
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial InfarctionGorav Batra, Lars Lindhagen, Pontus Andell, et al.
Pageof 4